Tigertriever Distal Vessels Registry

NCT03871309 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2024-04-12

No results posted yet for this study

Summary

A registry study to collect data on the Tigertriever device at restoring blood flow by removing clots in M2 or distal vessels in patients experiencing acute ischemic stroke, during commercial use.

Conditions

Interventions

DEVICE

Tigertriever

Mechanical Thrombectomy

Sponsors & Collaborators

  • Rapid Medical

    lead INDUSTRY

Principal Investigators

  • Kyri Lobotesis, MD · Imperial College Healthcare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-07
Primary Completion
2022-08-04
Completion
2023-10-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03871309 on ClinicalTrials.gov